Interim report January – March 2023
Promore Pharma AB (publ) published the interim report for january – march 2023 on May 23, 2023
Promore Pharma AB (publ) published the interim report for january – march 2023 on May 23, 2023
Promore Pharma is a biopharmaceutical company specialized in the development of therapeutic peptides for the bioactive wound care market. The company’s aim is to develop two first-in-category products for indications with very few efficacious prescription pharmaceuticals, addressing high unmet medical need.
Within the global wound care market Promore Pharma’s product candidates are intended for the bioactive wound care segment. The bioactive wound care segment constitutes the fastest growing segment within the overall wound care market with a projected annual growth rate of approximately 6 percent and is expected to reach USD 12 billion in 2024.